The mechanisms and outcomes of cancer treatment–related cardiovascular dysfunction are complex and influenced by cardiotoxic treatment exposure, preexisting heart disease, and lifestyle factors. Establishing and implementing evidence to prevent, detect, and manage cancer treatment–related cardiotoxicity requires engagement by the nursing science community.